These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28588050)

  • 1. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses.
    Zhang Z; Imperial MZ; Patilea-Vrana GI; Wedagedera J; Gaohua L; Unadkat JD
    Drug Metab Dispos; 2017 Aug; 45(8):920-938. PubMed ID: 28588050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.
    Zhang Z; Unadkat JD
    Drug Metab Dispos; 2017 Aug; 45(8):939-946. PubMed ID: 28049636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of Fetal-to-Maternal Unbound Steady-State Plasma Concentration Ratio of P-Glycoprotein and/or Breast Cancer Resistance Protein Substrate Drugs Using a Maternal-Fetal Physiologically Based Pharmacokinetic Model.
    Peng J; Ladumor MK; Unadkat JD
    Drug Metab Dispos; 2022 May; 50(5):613-623. PubMed ID: 35149540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime, and Amoxicillin during Pregnancy Using Bottom-Up Physiologically Based Pharmacokinetic Models.
    Abduljalil K; Ning J; Pansari A; Pan X; Jamei M
    Drug Metab Dispos; 2022 Apr; 50(4):386-400. PubMed ID: 35046066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Human Fetal Drug Exposure Through Maternal-Fetal PBPK Modeling and In Vitro or Ex Vivo Studies.
    Balhara A; Kumar AR; Unadkat JD
    J Clin Pharmacol; 2022 Sep; 62 Suppl 1(Suppl 1):S94-S114. PubMed ID: 36106781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Maternal and Fetal Acyclovir, Emtricitabine, Lamivudine, and Metformin Concentrations during Pregnancy Using a Physiologically Based Pharmacokinetic Modeling Approach.
    Abduljalil K; Pansari A; Ning J; Jamei M
    Clin Pharmacokinet; 2022 May; 61(5):725-748. PubMed ID: 35067869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating fetal exposure to the P-gp substrates, corticosteroids, by PBPK modeling to inform prevention of neonatal respiratory distress syndrome.
    Anoshchenko O; Milad MA; Unadkat JD
    CPT Pharmacometrics Syst Pharmacol; 2021 Sep; 10(9):1057-1070. PubMed ID: 34273255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Prediction of Human Fetal Exposure to P-Glycoprotein Substrate Drugs Using the Proteomics-Informed Relative Expression Factor Approach and PBPK Modeling and Simulation.
    Anoshchenko O; Storelli F; Unadkat JD
    Drug Metab Dispos; 2021 Oct; 49(10):919-928. PubMed ID: 34426410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Various Approaches to Estimate Transplacental Clearance of Vancomycin for Predicting Fetal Concentrations using a Maternal-Fetal Physiologically Based Pharmacokinetic Model.
    Yan Y; Wang Q; Wu W; Yi H; Xie F
    Pharm Res; 2024 May; 41(5):899-910. PubMed ID: 38684563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models.
    De Sousa Mendes M; Hirt D; Vinot C; Valade E; Lui G; Pressiat C; Bouazza N; Foissac F; Blanche S; Lê MP; Peytavin G; Treluyer JM; Urien S; Benaboud S
    Br J Clin Pharmacol; 2016 Apr; 81(4):646-57. PubMed ID: 26518984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational Age-Dependent Abundance of Human Placental Transporters as Determined by Quantitative Targeted Proteomics.
    Anoshchenko O; Prasad B; Neradugomma NK; Wang J; Mao Q; Unadkat JD
    Drug Metab Dispos; 2020 Sep; 48(9):735-741. PubMed ID: 32591415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Pharmacokinetic Model of Transplacental Transfer of Metformin to Predict In Vivo Fetal Exposure.
    Kurosawa K; Chiba K; Noguchi S; Nishimura T; Tomi M
    Drug Metab Dispos; 2020 Dec; 48(12):1293-1302. PubMed ID: 33051249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of Placental Transfer in a Fetal-Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus.
    Mian P; Allegaert K; Conings S; Annaert P; Tibboel D; Pfister M; van Calsteren K; van den Anker JN; Dallmann A
    Clin Pharmacokinet; 2020 Jul; 59(7):911-925. PubMed ID: 32052378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodological Approaches to Evaluate Fetal Drug Exposure.
    Bouazza N; Foissac F; Hirt D; Urien S; Benaboud S; Lui G; Treluyer JM
    Curr Pharm Des; 2019; 25(5):496-504. PubMed ID: 30892158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic Framework to Predict Maternal-Placental-Fetal Pharmacokinetics of Nifedipine Employing Physiologically Based Pharmacokinetic Modeling Approach.
    Werdan Romão MA; Pinto L; Cavalli RC; Duarte G; de Moraes NV; Abduljalil K; Moreira FL
    J Clin Pharmacol; 2024 May; 64(5):568-577. PubMed ID: 38305718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based pharmacokinetic modeling approach.
    Van Der Heijden JEM; Van Hove H; Van Elst NM; Van Den Broek P; Van Drongelen J; Scheepers HCJ; De Wildt SN; Greupink R
    Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38763343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of placental and lactational transfer and tissue distribution of atrazine and its main metabolites in rodent dams, fetuses, and neonates with physiologically based pharmacokinetic modeling.
    Lin Z; Fisher JW; Wang R; Ross MK; Filipov NM
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):140-58. PubMed ID: 23958493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of transplacental clearances and fetal clearance to drug disposition in the ovine maternal-fetal unit.
    Szeto HH; Umans JG; Rubinow SI
    Drug Metab Dispos; 1982; 10(4):382-6. PubMed ID: 6126338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir.
    Liu XI; Momper JD; Rakhmanina N; van den Anker JN; Green DJ; Burckart GJ; Best BM; Mirochnick M; Capparelli EV; Dallmann A
    J Clin Pharmacol; 2020 Feb; 60(2):240-255. PubMed ID: 31489678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Maternal-Fetal Disposition of Fentanyl Following Intravenous and Epidural Administration Using Physiologically Based Pharmacokinetic Modeling.
    Shum S; Shen DD; Isoherranen N
    Drug Metab Dispos; 2021 Nov; 49(11):1003-1015. PubMed ID: 34407992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.